Literature DB >> 25437587

Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.

Georgios Tsoulfas1, Polyxeni Agorastou, Andreas Tooulias, Georgios N Marakis.   

Abstract

Challenges in the treatment of hepatocellular carcinoma Hepatocellular carcinoma (HCC) represents one of the most frequent types of cancer worldwide. Surgery, although only a part of the armamentarium against HCC, represents the cornerstone in the management of this aggressive disease. This article will review the current and future challenges in the surgical management of HCC, with a special emphasis on the following areas: (1) the evolution of staging of the disease and the importance of the biological nature and behavior of HCC, (2) the effort to increase resectability, (3) technical innovations and the role of image-guided surgery, and, finally, (4) the role of liver transplantation in the continuum of care for these patients. Although by no means an exhaustive list, the issues mentioned above represent some of the most promising prospects for significant progress in the management of HCC.

Entities:  

Keywords:  Hepatocellular carcinoma; Image-guided surgery; Liver transplantation; Resectability

Mesh:

Year:  2014        PMID: 25437587      PMCID: PMC4254240          DOI: 10.9738/INTSURG-D-13-00122.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  55 in total

1.  In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection.

Authors:  W T Knoefel; I Gabor; A Rehders; A Alexander; M Krausch; J Schulte am Esch; G Fürst; S A Topp
Journal:  Br J Surg       Date:  2012-11-02       Impact factor: 6.939

Review 2.  Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.

Authors:  A N Gordon-Weeks; A Snaith; T Petrinic; P J Friend; A Burls; M A Silva
Journal:  Br J Surg       Date:  2011-05-27       Impact factor: 6.939

3.  Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators.

Authors: 
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

4.  Identifying targets of miR-143 using a SILAC-based proteomic approach.

Authors:  Yi Yang; Raghothama Chaerkady; Kumaran Kandasamy; Tai-Chung Huang; Lakshmi Dhevi N Selvan; Sutopa B Dwivedi; Oliver A Kent; Joshua T Mendell; Akhilesh Pandey
Journal:  Mol Biosyst       Date:  2010-06-14

5.  Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.

Authors:  Elizabeth A Pomfret; Kenneth Washburn; Christoph Wald; Michael A Nalesnik; David Douglas; Mark Russo; John Roberts; David J Reich; Myron E Schwartz; Luis Mieles; Fred T Lee; Sander Florman; Francis Yao; Ann Harper; Erick Edwards; Richard Freeman; John Lake
Journal:  Liver Transpl       Date:  2010-03       Impact factor: 5.799

6.  How to avoid postoperative liver failure: a novel method.

Authors:  Eduardo de Santibañes; Fernando A Alvarez; Victoria Ardiles
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

7.  Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy.

Authors:  Toshiya Shibata; Yuji Iimuro; Yuzo Yamamoto; Yoji Maetani; Fumie Ametani; Kyo Itoh; Junji Konishi
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

8.  Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis.

Authors:  S J Cheng; D S Pratt; R B Freeman; M M Kaplan; J B Wong
Journal:  Transplantation       Date:  2001-09-15       Impact factor: 4.939

Review 9.  Hepatocellular carcinoma: new options for image-guided ablation.

Authors:  Riccardo Lencioni; Dania Cioni; Clotilde Della Pina; Laura Crocetti
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-12-01       Impact factor: 7.027

10.  Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.

Authors:  Junichi Shindoh; Jean-Nicolas Vauthey; Giuzeppe Zimmitti; Steven A Curley; Steven Y Huang; Armeen Mahvash; Sanjay Gupta; Michael J Wallace; Thomas A Aloia
Journal:  J Am Coll Surg       Date:  2013-04-28       Impact factor: 6.113

View more
  4 in total

1.  Relationship between ADH2 Arg47His variation and hepatocellular carcinoma susceptibility: a meta analysis.

Authors:  Shuzhen Liu; Yongchun Cui; Baohong Yang; Ping Chai; Zheng Su; Qianqian Zhang; Dejie Zheng; Rui Li; Guohua Yu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.

Authors:  Runchen Miao; Xinsen Xu; Zhixin Wang; Sushun Liu; Kai Qu; Wei Chen; Chang Liu
Journal:  Mol Med Rep       Date:  2017-12-22       Impact factor: 2.952

3.  Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro.

Authors:  Yuhang Tian; Zhao Liu; Lei Zhang; Jia Zhang; Xue Han; Qiucheng Wang; Wen Cheng
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

4.  Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma.

Authors:  Dan Yue; Xun Sun
Journal:  Cell Death Dis       Date:  2018-09-17       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.